Overexpression of 5-lipoxygenase increases the neuronal vulnerability of PC12 cells to aβ42

Yakugaku Zasshi

Volumn 131, Issue 12, 2011, Pages 1843-1853

  Wang, Ze Jian ^a   Zhou, Bin ^a   Mao, Wen Wei ^a   Yin, Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

5 lipoxygenase; Alzheimer's disease; Amyloid protein; Apoptosis; Peroxide

Indexed keywords

ABETA 42 PROTEIN; AMYLOID BETA PROTEIN; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE; CASPASE 3; CATALASE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDASE; PEROXIDE; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CLONE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; IMMUNOBLOTTING; NERVE CELL; PROTEIN EXPRESSION; UPREGULATION;

EID: 82755184885     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.131.1843     Document Type: Article

References (29)

1. Giunta B., Fernandez F., Nikolic W. V., J. Neuroinflammation., 11, 11-115 (2008).
2. Peters-Golden M., Curr. Allergy. Asthma. Rep., 8, 367-373 (2008).
3. Manev H., Uz T., Ann. N. Y. Acad. Sci., 890, 183-190(1999).
4. Chinnici C. M., Yao Y., Pratico D., Neurobiol. Aging., 28, 1457-1462 (2006).
5. Qu T., Uz T., Manev H., Neurobiol. Aging., 21, 647-652 (2000).
6. Lammers C. H., Schweitzer P., Facchinetti P., Arrang J. M., Madamba S. G., Siggins G. R., Piomelli D., J. Neurochem., 66, 147-152 (1996).
7. Mayatepek E., Zelezny R., Lehmann W. D., Hammond J. W., Hoffmann G. F., J. Inherit. Metab. Dis., 23, 404-408 (2000).
8. Schweiger D., Furstenberger G., Krieg P., J. Lipid. Res., 48, 553-564 (2007).
9. Ishii K., Yoshida Y., Akechi Y., Sakabe T., Nishio R., Ikeda R., Terabayashi K., Matsumi Y., Gonda K., Okamoto H., Takubo K., Tajima F., Tsuchiya H., Hoshikawa Y., Kurimasa A., Umezawa A., Shiota G., Hepatology., 48, 597-606 (2008).
10. Melstrom L. G., Bentrem D. J., Salabat M. R., Kennedy T. J., Ding X. Z., Strouch M., Rao S. M., Witt R. C., Ternent C. A., Talamonti M. S., Bell R. H., Adrian T. A., Clin. Cancer Res., 14, 6525-6530 (2008).
11. Chen X. S., Funk C. D., J. Bio. Chem., 276, 811-818 (2001).
12. Jung C. S., Kim M. J., Heo H. J., Kim J. K., Jin J. W., Kim H. K., Kim E. K., Ok Kim M., Yon C. H., Hwang H. J., Jun K. Y., Shin D. H., Amyloid, 16, 15-24 (2009).
13. Wang Z. J., Liang C. L., Li G. M., Yu C. Y., Yin M., Acta Pharmacol. Sin., 28, 315-326 (2007).
14. Provost P., Doucet J., Hammarberg T., Gerisch G., Samuelsson B., Radmark O., J. Biol. Chem., 276, 16520-16527 (2001).
15. Hempel S. L., Buettner G. R., O'Malley Y. Q, Wessels D. A., Flaherty D. M., Free Radic. Biol. Med., 27, 146-159 (1999).
16. Ghribi O., Prammonjago P., Herman M. M., Spaulding N. K., Savory J., Mol. Brain Res., 119, 201-206 (2003).
17. Rådmark O. P., Am. J. Respir. Crit. Care Med., 161, S11-S15 (2000).
18. Peters-Golden M., Clin. Exp. Allergy Rev., 1, 128-132 (2001).
19. Cunningham C., Campion S., Lunnon K., Murray C. L., Woods J. F., Deacon R. M., Rawlins J. N., Perry V. H., Biol. Psychiatry, 65, 304-312 (2009).
20. Ikonomovic M. D., Abrahamson E. E., Uz T., Manev H., Dekosky S. T., J. Histochem. Cytochem., 56, 1065-1073 (2008).
21. Prasad V. V., Nithipatikom K., Harder D. R., Neurochem. Int., 53, 220-229 (2008).
22. Shin V. Y., Jin H. C., Ng E. K., Sung J.J., Chu K. M., Cho C. H., J. Neuropathol. Exp. Neurol., 59, 271-279 (2000).
23. Bodles A. M., Guthrie D. J., Greer B., Irvine, G. B., J. Neurochem., 78, 384-395 (2001)
24. Klein J. A., Ackerman S. L., J. Clin. Invest., 116, 785-793 (2003).
25. Catalano A., Rodilossi S., Caprari P., Coppola V., Procopio A., EMBO J., 24, 170-179 (2005).
26. Veal E. A., Day A. M., Morgan B. A., Mol. Cell, 26, 1-14 (2007).
27. Sridevi N., Venkataraman P., Senthilkumar K., Krishnamoorthy G., Arunakaran J., Biomed. Pharmacother., 61, 435-440 (2007).
28. Wang L. Y., Chanvorachote P., Toledo D., Mol. Pharmacol., 73, 119-127 (2008).
29. Maianski N. A., Roos D., Kuijpers T. W., J. Immunol., 172, 7024-7030 (2004).